TScan Therapeutics Appoints Heather Savelle as Vice President, Investor Relations

TScan Therapeutics to Participate in the Chardan 5th Annual Genetic Medicines Conference

TScan Therapeutics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

TScan Therapeutics to Present Discovery of T Cell Targets for COVID-19 at the Cell-Mediated Therapies for Infectious Disease Summit

TScan Therapeutics, Inc. Announces Pricing of Initial Public Offering

TScan Therapeutics Adds to Executive Leadership Team and Board of Directors

TScan Therapeutics Appoints Katina Dorton, J.D., M.B.A., to Its Board of Directors

TScan Therapeutics Strengthens Leadership Team with the Appointment of Brian M. Silver as Chief Financial Officer

TScan Therapeutics Announces $100 Million Series C Financing

TScan Therapeutics Appoints Brian M. Silver, J.D., to Its Board of Directors